{"id":6364,"text":" Edited by:   Reviewed by:    These authors have contributed equally to this work and share first authorship This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology  Background: Digoxin is one of the most widely and commonly used cardiac drug, which plays an irreplaceable role in treating heart failure and arrhythmia.","label":[[222,230,"Drug"],[334,347,"Pathology"],[352,362,"Pathology"]],"Comments":[]}
{"id":6365,"text":"The 2010 Edition of Pharmacopoeia of the People’s Republic of China stipulates that the effective range of digoxin plasma concentration is 0.5–2.0 ng\/mL and it is toxic at plasma concentration >2 ng\/mL.","label":[[106,114,"Drug"],[106,135,"Parameter"],[138,152,"Amount"],[163,192,"Parameter"],[193,201,"Amount"]],"Comments":[]}
{"id":6366,"text":"Its effective plasma drug concentration is close to the toxic concentration, and large individual differences in the effects of the drug have been observed.","label":[],"Comments":[]}
{"id":6367,"text":"It is often used in combination with other drugs, but drug interactions have a great impact on the plasma concentration of digoxin and lead to adverse reactions (ADRs), such as poisoning.","label":[[99,130,"Parameter"],[123,131,"Drug"],[143,160,"Pathology"],[177,186,"Pathology"]],"Comments":[]}
{"id":6368,"text":"Most of the reported drug interactions are with Western drugs.","label":[],"Comments":[]}
{"id":6369,"text":"However, there are many combinations of traditional Chinese medicine (TCM) and Western drugs, TCM interacting with digoxin comprises monomer components, single medicines, and Chinese patent medicines.","label":[[52,60,"Ethnic group"],[115,123,"Drug"],[175,183,"Ethnic group"]],"Comments":[]}
{"id":6370,"text":"Aim of the study: We aimed i) to provide an overview of the TCM formulations affecting the pharmacology of digoxin and their mechanisms of action and ii) to provide a theoretical reference for the safe and rational use of digoxin in combination with TCM in clinical practice and to avoid ADRs.","label":[[107,115,"Drug"],[222,230,"Drug"],[288,292,"Pathology"]],"Comments":[]}
{"id":6371,"text":"Methods: A literature search of electronic databases, including PubMed, MEDLINE, Cochrane Library, Web of Science, China National Knowledge Infrastructure, and WANFANG Data, was performed to search for articles published between 1 January 1960, and 1 August 2022.","label":[],"Comments":[]}
{"id":6372,"text":"Search terms used included “digoxin,” “traditional Chinese medicine,” “Chinese patent medicine,” and “adverse reactions” and their combinations.","label":[[28,35,"Drug"],[51,59,"Ethnic group"],[71,79,"Ethnic group"],[102,119,"Pathology"]],"Comments":[]}
{"id":6373,"text":"Results: A total of 49 articles were obtained, including clinical reports, pharmacological experiments and in vitro experiments.","label":[],"Comments":[]}
{"id":6374,"text":"The mechanisms of action affecting the pharmacology of digoxin are complex.","label":[[55,63,"Drug"]],"Comments":[]}
{"id":6375,"text":"TCM formulations may affect the pharmacology of digoxin in vivo by influencing gastrointestinal motility or gastric juice pH, regulating P-glycoprotein levels, exerting cumulative pharmacological effects, and enhancing the sensitivity of the heart to digoxin.","label":[[48,56,"Drug"],[79,105,"Parameter"],[107,124,"Parameter"],[126,158,"Parameter"],[251,258,"Drug"]],"Comments":[]}
{"id":6376,"text":"Although studies have shown that some TCM formulations interact with digoxin, they may be influenced by the complexity of the composition and the pharmacological effects of the TCM, the sensitivity of digoxin concentration determination methods, etc.","label":[],"Comments":[]}
{"id":6377,"text":"The results of existing studies are controversial and further in-depth studies are required.","label":[],"Comments":[]}
{"id":6378,"text":"Conclusion: Combinations of digoxin and TCM formulations are commonly used.","label":[[28,36,"Drug"]],"Comments":[]}
{"id":6379,"text":"This article serves as a reference to understand the interactions between TCM formulations and digoxin to avoid the occurrence of ADRs and improve the efficacy and safety of digoxin.","label":[[95,103,"Drug"],[130,135,"Pathology"],[174,181,"Drug"]],"Comments":[]}
{"id":6380,"text":"Digoxin is a pure preparation derived from the leaves of Digitalis lanata Ehrh (Maohuayangdihuang).","label":[[0,8,"Drug"],[57,98,"Herb name"]],"Comments":[]}
{"id":6381,"text":"It is a cardiac glycoside commonly used in clinical practice for the treatment of heart failure, atrial fibrillation, and other arrhythmias (Srinivasan et al., 2020).","label":[[81,95,"Pathology"],[97,116,"Pathology"],[128,139,"Pathology"]],"Comments":[]}
{"id":6382,"text":"There is significant individual variation in patient response to digoxin therapy, and an important reason for this variation is that the disposition and sensitivity of patients to the drug vary greatly.","label":[[65,73,"Drug"]],"Comments":[]}
{"id":6383,"text":"Digoxin shows large individual variation in vivo.","label":[[0,8,"Drug"]],"Comments":[]}
{"id":6384,"text":"It has a narrow therapeutic window, i.e., the therapeutic concentration is close to the toxic concentration; its effective plasma concentration is 0.5–1.5 ng\/mL and it is toxic at plasma concentration >2 ng\/mL.","label":[[113,143,"Parameter"],[147,160,"Amount"],[170,201,"Parameter"],[201,209,"Amount"]],"Comments":[]}
{"id":6385,"text":"Moreover, its efficacy is influenced by several factors (Liu et al., 2016), including drug interactions.","label":[],"Comments":[]}
{"id":6386,"text":"Digoxin is one of the 10 drugs with the most drug interactions, and the incidence of adverse reactions (ADRs) due to interactions is as high as 27% (Sun, 1982).","label":[[0,8,"Drug"],[85,109,"Pathology"]],"Comments":[]}
{"id":6387,"text":"Most of these reports and studies are on combinations with Western drugs.","label":[],"Comments":[]}
{"id":6388,"text":"In this paper, we summarize the interactions of digoxin with other drugs and their mechanisms of action from a pharmacological point of view by summarizing basic research, clinical studies, treatment guidelines and monographs, to provide a reference for its safe clinical use.","label":[[48,56,"Drug"],[171,188,"Study"]],"Comments":[]}
{"id":6389,"text":"A literature search of electronic databases, including PubMed, MEDLINE, Cochrane Library, Web of Science, China National Knowledge Infrastructure, and WANFANG Data, was performed to search for articles published between 1 January 1960 and 1 August 2022.","label":[],"Comments":[]}
{"id":6390,"text":"Search terms used included “digoxin”, “Chinese medicine”, “traditional Chinese medicine”, “Chinese patent medicine”, “adverse reactions” and their combinations.","label":[[28,35,"Drug"],[71,79,"Ethnic group"],[91,99,"Ethnic group"],[118,135,"Pathology"]],"Comments":[]}
{"id":6391,"text":"The inclusion criteria included the following: a.","label":[],"Comments":[]}
{"id":6392,"text":"Clear literatures on the experimental and clinical research on the interactions between TCM formulations and digoxin.","label":[[109,116,"Drug"]],"Comments":[]}
{"id":6393,"text":"b. Literatures written in English and Chinese.","label":[[38,45,"Ethnic group"]],"Comments":[]}
{"id":6394,"text":"The exclusion criteria were as follows: a. Literatures without mechanisms of interactions between TCM formulations and digoxin; b.","label":[[119,126,"Drug"]],"Comments":[]}
{"id":6395,"text":"Literature review, expert experience introduction and other types of literature; c. For the content of the repeatedly published literature.","label":[],"Comments":[]}
{"id":6396,"text":"A total of 49 articles were obtained, including clinical reports, pharmacological experiments and in vitro experiments which were reviewed to determine the mechanism of interactions between TCM and digoxin.","label":[[198,205,"Drug"]],"Comments":[]}
{"id":6397,"text":"Oral and injectable digoxin formulations exist.","label":[[20,28,"Drug"]],"Comments":[]}
{"id":6398,"text":"Because the injection is prone to ADRs and is only suitable for patients with severe heart failure requiring immediate treatment, oral formulations are more frequently used.","label":[[34,38,"Pathology"],[78,98,"Pathology"]],"Comments":[]}
{"id":6399,"text":"Thus, this article focuses on the pharmacokinetic processes of oral formulations.","label":[],"Comments":[]}
{"id":6400,"text":"Digoxin is absorbed orally through the small intestine, with incomplete and irregular absorption.","label":[[0,8,"Drug"]],"Comments":[]}
{"id":6401,"text":"The absorption rate is about 75%, the onset of action is at 0.5–2 h, the peak plasma concentration is observed at 2–3 h, and the maximum effect is observed at 4–8 h. After absorption, it is widely distributed to various tissues, such as the heart, bone, muscle, liver, and kidney (Bai et al., 2014).","label":[[72,98,"Parameter"]],"Comments":[]}
{"id":6402,"text":"It is partly absorbed into the blood via the biliary tract, forming hepatic-intestinal circulation, with a low plasma protein binding rate of 20%–25% and an apparent volume of distribution (V When digoxin is used in combination with gastrointestinal stimulants, gastrointestinal stimulants may increase the clearance of digoxin because they promote gastric emptying and intestinal peristalsis; changes in the pH value of the gastrointestinal tract also affect the absorption of digoxin (Li and Pan, 2011).","label":[[157,188,"Parameter"],[197,205,"Drug"],[307,317,"Parameter"],[320,328,"Drug"],[464,485,"Parameter"],[478,486,"Drug"]],"Comments":[]}
{"id":6403,"text":"In addition, some bacteria present in the gastrointestinal tract may affect the pharmacokinetic parameters of digoxin.","label":[[110,117,"Drug"]],"Comments":[]}
{"id":6404,"text":"For example, digoxin can be partially metabolized by intestinal anaerobic bacteria, including Bifidobacterium after oral administration of non-cardiogenic dihydrodigoxin and dihydrodigoxin sapogenins, which decreases the plasma concentration of digoxin (Bai et al., 2014).","label":[[13,21,"Drug"],[138,170,"Herb name"],[174,199,"Herb name"],[221,252,"Parameter"],[245,253,"Drug"]],"Comments":[]}
{"id":6405,"text":"Drug transporters are among the main factors affecting the in vivo disposal of drugs.","label":[],"Comments":[]}
{"id":6406,"text":"P-glycoprotein (P-gP), which belongs to the superfamily of ATP-binding cassette (ABC) transporters, is the main efflux protein in humans.","label":[],"Comments":[]}
{"id":6407,"text":"P-gP is mainly expressed on capillary endothelial cells in the small intestine, liver, kidney, and blood-brain barrier (Thiebaut et al., 1987).","label":[],"Comments":[]}
{"id":6408,"text":"Its main function is to excrete intracellular toxic substances and exogenous substances such as drugs through the gastrointestinal tract, bile, or urine.","label":[],"Comments":[]}
{"id":6409,"text":"Since the activity of P-gP can affect the plasma concentration, bioavailability, tissue distribution, and liver and kidney clearance rate (CL) of the drug (Herfindal et al., 2011), during co-administration, certain drugs can act as substrates, P-gP inhibitors, or P-gP inducers, causing changes in the plasma concentration of the co-administered drugs leading to interactions.","label":[[42,62,"Parameter"],[64,79,"Parameter"],[81,100,"Parameter"],[106,142,"Parameter"],[243,248,"Target"],[263,269,"Target"],[302,322,"Parameter"]],"Comments":[]}
{"id":6410,"text":"Digoxin is a substrate of P-gP.","label":[[0,8,"Drug"],[26,31,"Target"]],"Comments":[]}
{"id":6411,"text":"P-gP mediates the renal excretion of digoxin while promoting the absorption process in the small intestine (Mamidi, et al., 2017).","label":[[0,4,"Target"],[37,45,"Drug"]],"Comments":[]}
{"id":6412,"text":"When digoxin is combined with drugs such as P-gP inhibitors or P-gP inducers, changes in the pharmacokinetic parameters of digoxin may be caused by altered P-gP expression or activity in the intestinal wall, thus altering the bioavailability of digoxin (Li et al., 2011).","label":[[5,13,"Drug"],[43,50,"Target"],[62,68,"Target"],[123,131,"Drug"],[156,160,"Target"],[226,242,"Parameter"],[245,253,"Drug"]],"Comments":[]}
{"id":6413,"text":"Digoxin belongs to cardiac glycosides and has a positive inotropic effect.","label":[[0,8,"Drug"]],"Comments":[]}
{"id":6414,"text":"It acts directly on myocardial cells, inhibits Na Low blood potassium level is the most important factor affecting digoxin toxicity (Du et al., 2016).","label":[[47,50,"Target"],[115,123,"Drug"]],"Comments":[]}
{"id":6415,"text":"Blood potassium levels are positively correlated with cardiomyocyte potassium channel permeability, and low potassium levels inhibit cardiomyocyte potassium outflow, leading to increased cardiac autoregulation and inducing cardiac arrhythmias caused by cardiac glycosides.","label":[[0,23,"Parameter"],[223,242,"Pathology"]],"Comments":[]}
{"id":6416,"text":"Endogenous digoxin substances are present in neonates and patients with renal dysfunction, and these substances may lead to elevated or false-positive digoxin plasma concentration monitoring results.","label":[[11,19,"Drug"],[58,67,"Pathology"],[72,89,"Pathology"],[151,159,"Drug"]],"Comments":[]}
{"id":6417,"text":"Patients with higher body weight have a large V Pharmacogenomic studies of digoxin revealed that polymorphisms at certain loci can affect the metabolism and action of digoxin.","label":[[0,9,"Pathology"],[40,72,"Study"],[75,83,"Drug"],[167,174,"Drug"]],"Comments":[]}
{"id":6418,"text":"For example, digoxin plasma concentration in patients with 3435 TT (3.74 ± 1.06 ng\/mL) and 2677 GG (3.40 ± 1.35 ng\/mL) phenotypes is significantly higher than in patients with 3435CC\/CT (0.79 ± 1.06 ng\/mL\/1.24 ± 0.66 ng\/mL) and 2677TT\/TG (1.31 ± 1.20 ng\/mL\/1.47 ± 1.16 ng\/mL) genotypes, further suggesting that ABCB1 gene polymorphisms can affect digoxin plasma concentration (Jiang et al., 2019), thus explaining the uncommon effective digoxin dose in some patients.","label":[[13,21,"Drug"],[13,41,"Parameter"],[45,54,"Pathology"],[68,85,"Amount"],[100,117,"Amount"],[162,171,"Pathology"],[187,204,"Amount"],[205,222,"Amount"],[239,256,"Amount"],[257,274,"Amount"],[347,355,"Drug"],[347,376,"Parameter"],[437,445,"Drug"],[458,466,"Pathology"]],"Comments":[]}
{"id":6419,"text":"Yan et al.","label":[],"Comments":[]}
{"id":6420,"text":"(2015) studied the clinical effects and differences in plasma concentration of digoxin in the treatment of Uyghur and Han Chinese heart failure patients.","label":[[55,86,"Parameter"],[79,87,"Drug"],[122,130,"Ethnic group"],[130,152,"Pathology"]],"Comments":[]}
{"id":6421,"text":"Their results showed that the efficacy of digoxin in the treatment of heart failure in Uyghur and Han Chinese was comparable, but digoxin plasma concentration was significantly higher in the Han Chinese group (1.41 ± 0.43 ng\/mL) than in the Uyghur group (0.96 ± 0.39 ng\/mL).","label":[[42,50,"Drug"],[70,83,"Pathology"],[87,93,"Ethnic group"],[102,110,"Ethnic group"],[130,138,"Drug"],[130,159,"Parameter"],[195,203,"Ethnic group"],[210,227,"Amount"],[241,248,"Ethnic group"],[255,272,"Amount"]],"Comments":[]}
{"id":6422,"text":"Based on our analysis of the literature, the mechanism of interaction between TCM formulations and digoxin is as follows: A.","label":[[99,106,"Drug"]],"Comments":[]}
{"id":6423,"text":"Effect of TCM on pharmacokinetic mechanism of digoxin i) they can influence the state of the gastrointestinal tract and affect digoxin absorption; ii) they can modulate P-gP expression\/activity and thereby influence digoxin disposal; B.","label":[[46,54,"Drug"],[126,145,"Parameter"],[127,135,"Drug"],[169,174,"Target"],[216,224,"Drug"]],"Comments":[]}
{"id":6424,"text":"Effect of TCM on Pharmacodynamics mechanism of digoxin iii) synergistic drug effects may occur, increasing the risk of digoxin poisoning; iv) they may enhance the sensitivity of the heart to digoxin and increase the risk of poisoning; and v) they may antagonize the ADRs caused by digoxin (Figure 1).","label":[[47,55,"Drug"],[119,127,"Drug"],[191,199,"Drug"],[266,270,"Pathology"],[281,289,"Drug"]],"Comments":[]}
{"id":6425,"text":"Schematic diagram of the mechanism of action between digoxin and traditional Chinese medicine.","label":[[53,61,"Drug"],[77,85,"Ethnic group"]],"Comments":[]}
{"id":6426,"text":"Anticholinergics can decrease intestinal peristalsis, prolong the passage time of digoxin in the upper part of the small intestine, increase digoxin absorption, and increase bioavailability (Qiu., 2016).","label":[[82,90,"Drug"],[131,159,"Parameter"],[141,149,"Drug"],[174,190,"Parameter"]],"Comments":[]}
{"id":6427,"text":"TCM formulations containing tropane alkaloids, such as belladonna tablets, increase the absorption and accumulation of cardiac glycosides in muscle tissue because of the relaxing effect of tropane alkaloids on smooth muscle tissue and reduced gastrointestinal motility, especially in patients with heart failure who are sensitive to the effects of cardiac glycosides and prone to toxic reactions.","label":[[28,45,"Herb name"],[54,73,"Herb name"],[87,138,"Parameter"],[188,206,"Herb name"],[243,268,"Parameter"],[284,293,"Pathology"],[298,312,"Pathology"]],"Comments":[]}
{"id":6428,"text":"A study on the effect of gastric juice pH on the biotransformation of digoxin was carried out.","label":[[25,41,"Parameter"],[48,77,"Parameter"],[70,78,"Drug"]],"Comments":[]}
{"id":6429,"text":"Two groups were given gastrin and normal saline respectively in addition to  Wheat bran is the seed coat of the grass plant wheat, which harmonizes the middle and benefits the spleen (Wu et al., 2014).","label":[[77,88,"Herb name"]],"Comments":[]}
{"id":6430,"text":"Wheat bran itself has little effect on digoxin, but if ingested at the same time as digoxin, it may form a bond with digoxin, which affects the absorption of digoxin and reduces digoxin plasma concentration (31.2% less than digoxin alone), thus, reducing the bioavailability of digoxin (Reissell and Manninen, 1982).","label":[[0,11,"Herb name"],[38,47,"Drug"],[84,91,"Drug"],[117,124,"Drug"],[143,166,"Parameter"],[158,165,"Drug"],[178,186,"Drug"],[185,207,"Parameter"],[224,232,"Drug"],[258,275,"Parameter"],[278,286,"Drug"]],"Comments":[]}
{"id":6431,"text":"TCM extracts: A study on the effect of citronellal on intestinal absorption of digoxin in vivo and in vitro was carried out.","label":[[39,51,"Herb name"],[53,76,"Parameter"],[79,87,"Drug"],[87,108,"Study"]],"Comments":[]}
{"id":6432,"text":"In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides “Chuanxiong” (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing).","label":[[9,17,"Drug"],[68,80,"Herb name"],[241,247,"Target"],[255,307,"Herb name"],[309,346,"Herb name"],[348,373,"Herb name"],[375,397,"Herb name"],[400,427,"Herb name"]],"Comments":[]}
{"id":6433,"text":"In addition to inhibiting P-gP expression by affecting intracellular Ca  Chinese patent medicine and decoction: Wuzhi Tablet is an ethanolic extract preparation of S. chinensis (Turcz.)","label":[[26,31,"Target"],[73,81,"Ethnic group"],[112,124,"Herb name"],[130,161,"Extraction process"],[164,177,"Herb name"]],"Comments":[]}
{"id":6434,"text":"Baill.","label":[],"Comments":[]}
{"id":6435,"text":"(Wuweizi), which is a commonly used hepatoprotective drug (Xin et al., 2011).","label":[[1,8,"Herb name"]],"Comments":[]}
{"id":6436,"text":"In combination with digoxin, S. chinensis (Turcz.)","label":[[20,27,"Drug"],[28,41,"Herb name"]],"Comments":[]}
{"id":6437,"text":"Baill.","label":[],"Comments":[]}
{"id":6438,"text":"(Wuweizi) methyl, ethyl, alcohol B, and ester A in Wuzhi Tablet can increase the plasma concentration of digoxin, respectively from 22.3 ± 13.3 ng h\/mL to 34.4 ± 23.4, 37.0 ± 14.2, 41.2 ± 15.1, and 39.0 ± 19.1 ng h\/mL, among which the effect of S. chinensis (Turcz.)","label":[[1,8,"Herb name"],[10,47,"Herb name"],[51,64,"Herb name"],[81,112,"Parameter"],[105,112,"Drug"],[132,217,"Amount"],[245,257,"Herb name"]],"Comments":[]}
{"id":6439,"text":"Baill.","label":[],"Comments":[]}
{"id":6440,"text":"(Wuweizi) alcohol B is the strongest.","label":[[0,19,"Herb name"]],"Comments":[]}
{"id":6441,"text":"Experiments in mice have shown that the AUC of digoxin is increased by gavage and intravenous injection.","label":[[40,44,"Parameter"],[47,55,"Drug"]],"Comments":[]}
{"id":6442,"text":"The AUC values of digoxin by gavage and intravenous injection were similar, suggesting that the plasma concentration of digoxin was increased mainly by inhibiting the clearance of digoxin in the liver and kidney.","label":[[4,8,"Parameter"],[18,26,"Drug"],[95,117,"Parameter"],[120,128,"Drug"],[167,211,"Parameter"],[180,188,"Drug"]],"Comments":[]}
{"id":6443,"text":"Cellular experiments showed that pentosidine, ethosidine, alcohol B, and ester A could inhibit the transport of digoxin in Caco-2 cells, suggesting that the above components could inhibit the activity of P-gP in vitro.","label":[[33,44,"Herb name"],[46,56,"Herb name"],[58,67,"Herb name"],[73,80,"Herb name"],[98,119,"Target"],[112,120,"Drug"],[204,208,"Target"]],"Comments":[]}
{"id":6444,"text":"In conclusion, Wuzhi Tablets elevate the plasma concentration of digoxin by inhibiting P-gP activity in the liver and kidney and reducing its elimination (Tan et al., 2018).","label":[[15,28,"Herb name"],[41,72,"Parameter"],[65,73,"Drug"],[86,125,"Target"]],"Comments":[]}
{"id":6445,"text":"Shaoyaogancao decoction is described in Zhang Zhongjing’s Treatise on Febrile Diseases.","label":[[0,23,"Herb name"],[69,86,"Pathology"]],"Comments":[]}
{"id":6446,"text":"It consists of two herbs, Paeonia lactiflora Pall (Baishao) and Glycyrrhiza glabra L. (Gancao).","label":[[26,59,"Herb name"],[63,94,"Herb name"]],"Comments":[]}
{"id":6447,"text":"When combined with digoxin, it has the potential to promote digoxin absorption and increase plasma concentration and thus bioavailability by downregulating P-gP expression and inhibiting P-gP function (Wang et al., 2012).","label":[[19,26,"Drug"],[60,68,"Drug"],[60,78,"Parameter"],[92,112,"Parameter"],[122,138,"Parameter"],[156,160,"Target"],[186,191,"Target"]],"Comments":[]}
{"id":6448,"text":"Some studies suggest that TCM formulations with induction effects on P-gP include silymarin, auraptene, Bupleurum chinense DC.","label":[[69,74,"Target"],[82,91,"Herb name"],[93,102,"Herb name"],[104,125,"Herb name"]],"Comments":[]}
{"id":6449,"text":"(Chaihu), Cyperus rotundus L. (Fuzi) and St. John’s wort (Guanyelianqiao).","label":[[1,7,"Herb name"],[10,28,"Herb name"],[31,35,"Herb name"],[41,73,"Herb name"]],"Comments":[]}
{"id":6450,"text":"Silymarin significantly induces mRNA expression of P-gP and may decrease the bioavailability of digoxin and reduce its efficacy (Wang, 2019), but a study from the University of Mississippi showed no significant effect of silymarin on pharmacokinetic parameters such as AUC, C Homology of medicine and food means that food and medicine have the same efficacy and no clear boundary in regulating human physiological function, and have the homology of source, composition and theory (Jia et al., 2021).","label":[[0,10,"Herb name"],[32,56,"Target"],[77,93,"Parameter"],[96,104,"Drug"],[221,231,"Herb name"],[269,272,"Parameter"]],"Comments":[]}
{"id":6451,"text":"Medicinal and edible homologous varieties interacting with digoxin include Citrus juices, Purple grape, Green tea and Areca catechu L. (Dasuan).","label":[[59,67,"Drug"],[75,88,"Herb name"],[90,102,"Herb name"],[104,113,"Herb name"],[118,143,"Herb name"]],"Comments":[]}
{"id":6452,"text":"Citrus juices such as orange juice, lemon juice, grape juice, and grapefruit juice contain a variety of flavonoid components with similar modulatory activity on digoxin transport as P-gP inhibitors, but the strength and characteristics of the effects depend on the distribution and classification of the flavonoid components (Xu et al., 2003).","label":[[22,34,"Herb name"],[36,47,"Herb name"],[49,60,"Herb name"],[65,83,"Herb name"],[104,114,"Herb name"],[161,169,"Drug"],[181,186,"Target"],[304,314,"Herb name"]],"Comments":[]}
{"id":6453,"text":"Purple grape is widely used for its health effects such as antioxidant activity, free radical scavenging, and anti-aging effects, and a study on the effect of purple grape on the pharmacokinetic parameters of digoxin in rats have confirmed that purple grape juice can inhibit P-gP in the gastrointestinal tract wall, and when used in combination with digoxin, it can increase pharmacokinetic parameters such as AUC (92.27%, 18.37 ± 1.67 ng h\/mL to 35.32 ± 5.58 ng h\/mL) and C  Venenum bufonis (Chansu) is the dried white pulp secreted from the skin glands and post-auricular glands of the Chinese toad or the black orbital toad, family Toadidae.","label":[[0,12,"Herb name"],[159,171,"Herb name"],[209,217,"Drug"],[245,263,"Herb name"],[276,280,"Target"],[351,358,"Drug"],[411,415,"Parameter"],[416,468,"Amount"],[589,597,"Ethnic group"]],"Comments":[]}
{"id":6454,"text":"The composition is complex, and the main components are toad toxin and toad venom ligands, all of which have the structure of cardiac glycosides of the toad steroidal dienolactone type, and animal experiments and clinical practice have proved that toad crisp, toad toxin, and toad venom ligands have cardiotonic effects, and their properties of action are similar to those of digitalis, but the cardiotonic effect is weaker (Dong, 2009; Chen, 2014).","label":[[376,385,"Drug"]],"Comments":[]}
{"id":6455,"text":"The crude venom of toad and one of its main components, toad venom ling, can enhance electrically driven contraction of isolated rat atria, constrict rat aortic rings, inhibit Na Commonly used Chinese patent medicines containing Venenum bufonis (Chansu) include Shexiangbaoxin Pill, Houtongxiaoyan Pill, Liushen Pill, Lushen Pill, and Jiuxin Pill.","label":[[193,201,"Ethnic group"]],"Comments":[]}
{"id":6456,"text":"These compounds are classified as “toad venom dienolide,” which is similar to digoxin in chemical structure and therefore elicits a digoxin-like immune response and inhibits Na  Nerium oleander L. (Jiazhutao) is a common cause of poisoning in Southeast Asia.","label":[[78,86,"Drug"],[132,139,"Drug"],[178,209,"Herb name"]],"Comments":[]}
{"id":6457,"text":"All parts of the N. oleander L. (Jiazhutao) shrub contain cardiac glycoside components that inhibit Na  Periploca sepium Bunge (Xiangjiapi) is widely used in Chinese medicine for the treatment of cardiac dysfunction, and its component periplocymarin has a strong cardiac glycoside structure with a strong affinity for Na  Panax ginseng C.A.Mey.","label":[[17,44,"Herb name"],[100,104,"Target"],[103,139,"Herb name"],[158,166,"Ethnic group"],[196,215,"Pathology"],[235,249,"Herb name"],[318,322,"Target"],[322,336,"Herb name"]],"Comments":[]}
{"id":6458,"text":"(Renshen) can strengthen the heart, raise the blood pressure, improve coronary flow, increase the body’s ability to resist hypoxia, reduce myocardial oxygen consumption, protect and repair cardiomyocytes, and exert certain anti-arrhythmic effects.","label":[[1,8,"Herb name"],[46,60,"Parameter"]],"Comments":[]}
{"id":6459,"text":"Some of its molecular structures are similar to those of digitalis glycosides, which are commonly used clinically in combination with digoxin for the treatment of coronary heart disease, heart failure, etc.","label":[[57,77,"Drug"],[134,142,"Drug"],[163,185,"Pathology"],[187,200,"Pathology"]],"Comments":[]}
{"id":6460,"text":"The combined therapeutic effects can enhance each other.","label":[],"Comments":[]}
{"id":6461,"text":"However, some studies have shown that P. ginseng (Renshen) does not affect the determination of serum digoxin (Chow et al., 2003).","label":[[37,59,"Herb name"],[102,110,"Drug"]],"Comments":[]}
{"id":6462,"text":"Shenmai injection promotes the renal excretion of digoxin and tends to decrease digoxin plasma concentration (Li et al., 2011).","label":[[0,18,"Herb name"],[50,58,"Drug"],[80,88,"Drug"],[80,108,"Parameter"]],"Comments":[]}
{"id":6463,"text":"A study on the effect of Shenmai Injection on digoxin blood concentration and pharmacokinetic parameters in dogs with heart failure showed that there are differences in the pharmacokinetic effects of different doses on digoxin, all of which tend to shorten digoxin t Ephedrine, the main component in Ephedra sinica Stapf (Caomahuang), has excitatory effects on cardiac α and β receptors, which excite the myocardium and enhance myocardial contractility.","label":[[25,42,"Herb name"],[46,54,"Drug"],[118,131,"Pathology"],[219,226,"Drug"],[257,265,"Drug"],[300,333,"Herb name"]],"Comments":[]}
{"id":6464,"text":"When combined with digoxin, E. sinica Stapf (Caomahuang) can enhance both the cardiotonic effects of digoxin and the toxic effects of digoxin on the heart, which can lead to toxic reactions including premature ventricular contractions, arrhythmia, and heart failure (Dong, 2009; Chen, 2014).","label":[[19,26,"Drug"],[28,56,"Herb name"],[101,109,"Drug"],[134,142,"Drug"],[200,234,"Pathology"],[236,246,"Pathology"],[252,265,"Pathology"]],"Comments":[]}
{"id":6465,"text":"Common Chinese patent medicines containing E. sinica Stapf include Jizhi syrup, Maxinzhike tablets, Tongxuanlifei pills, and Xiaokening tablets.","label":[[7,15,"Ethnic group"],[42,58,"Herb name"],[67,78,"Herb name"],[80,98,"Herb name"],[100,120,"Herb name"],[125,143,"Herb name"]],"Comments":[]}
{"id":6466,"text":"High serum Ca Commonly used clinical single Chinese medicines containing calcium include Os Draconis (Longgu), Os Tigris (Hugu), Os Pardi (Baogu), antler (Lujiao), rhinoceros horn (Xijiao), Saigae Tataricae Cornu (Lingyangjiao), Bubali Cornu (Shuiniaojiao), magnetitum (Cishi), alumen (Baifan), Gypsum Fibrosum (Shigao), stalactitum (Zhongrushi), ophicalcitum (Huaruishi), fluoritum (Zishiying), hematite (Daizheshi), Natrii Sulfas (Mangxiao), calamina (Luganshi), talcum (Huashi), chalcanthitum (Danfan), Haliotidis Concha (Shijueming), Ostreae Concha (Muli), Margaritifera Concha (Zhenzhumu), ark shell (Walengzi), Concha Meretricis Seu Cyclinae (Haigeqiao), cuttlebone (Haipiaoxiao), pangolin scales (Chuanshanjia), Testudinis Carapacis Et Plastri (Guijia), Turtle Carapace (Biejia),  The Qiliqiangxin capsule is a Chinese patent medicine for the treatment of chronic congestive heart failure (Chen and Pang, 2014).","label":[[44,52,"Ethnic group"],[89,109,"Herb name"],[111,127,"Herb name"],[129,145,"Herb name"],[147,162,"Herb name"],[164,188,"Herb name"],[190,227,"Herb name"],[229,256,"Herb name"],[258,276,"Herb name"],[278,293,"Herb name"],[295,319,"Herb name"],[321,345,"Herb name"],[347,371,"Herb name"],[373,394,"Herb name"],[396,416,"Herb name"],[418,442,"Herb name"],[444,463,"Herb name"],[465,480,"Herb name"],[482,504,"Herb name"],[506,536,"Herb name"],[538,559,"Herb name"],[561,593,"Herb name"],[595,615,"Herb name"],[617,659,"Herb name"],[661,685,"Herb name"],[687,717,"Herb name"],[719,759,"Herb name"],[761,785,"Herb name"],[792,812,"Herb name"],[818,826,"Ethnic group"],[863,895,"Pathology"]],"Comments":[]}
{"id":6467,"text":"Its ingredients, C. rotundus L. (Fuzi) and Descurainia sophia (L.) Webb ex Prantl (Tinglizi), contain cardiac glycoside components, such as strophanthigenin, evomonoside, and helveticoside, which have different degrees of cardiac strengthening effects (Ma and Gao, 2004; Wang et al., 2013).","label":[[16,38,"Herb name"],[43,66,"Herb name"],[66,92,"Herb name"],[140,156,"Herb name"],[158,169,"Herb name"],[175,188,"Herb name"]],"Comments":[]}
{"id":6468,"text":"When combined with digoxin it leads to increased digoxin plasma concentration, predisposes to digitalis toxicity, and is associated with patient age.","label":[[19,27,"Drug"],[49,57,"Drug"],[49,77,"Parameter"],[94,104,"Drug"]],"Comments":[]}
{"id":6469,"text":"The patients over 80 years old (27.5%) were more likely to be poisoned by the increase of digoxin concentration than those under 60 years old (15.30%), the proportion of digoxin poisoning in 60–80 years old patients (17.57%) was also higher than that under 60 years old (15.30%), but there was no statistical significance (Ye et al., 2019).","label":[[4,13,"Pathology"],[18,30,"Age"],[90,98,"Drug"],[129,142,"Age"],[170,178,"Drug"],[191,207,"Age"],[207,216,"Pathology"],[256,270,"Age"]],"Comments":[]}
{"id":6470,"text":"TCM formulations containing cardiac glycosides, such as  The main component of   Angelica sinensis (Oliv.)","label":[[28,46,"Herb name"],[80,106,"Herb name"]],"Comments":[]}
{"id":6471,"text":"Diels (Danggui), C. pinnatifida Bunge (Shanzha), and Calculus Bovis (Niuhuang) can antagonize digoxin-induced arrhythmias.","label":[[0,16,"Herb name"],[17,47,"Herb name"],[53,78,"Herb name"],[94,101,"Drug"],[110,121,"Pathology"]],"Comments":[]}
{"id":6472,"text":"A. sinensis (Oliv.)","label":[[0,19,"Herb name"],[19,777,"Herb name"]],"Comments":[]}
{"id":6473,"text":"Diels (Danggui) has antiarrhythmic effects and can antagonize digoxin-induced arrhythmias when combined with digoxin (Yang et al., 2019).","label":[[0,16,"Herb name"],[62,69,"Drug"],[78,90,"Pathology"],[109,117,"Drug"]],"Comments":[]}
{"id":6474,"text":"Li Xin et al.","label":[],"Comments":[]}
{"id":6475,"text":"used the duration of QRS interval prolongation, ventricular precontraction, ventricular tachycardia, and ventricular fibrillation as markers of arrhythmia to study the effects of C. pinnatifida Bunge (Shanzha) extract on digoxin-induced arrhythmias, and the results showed that the ventricular arrhythmias in the digoxin-induced experimental group of rats all decreased after the administration of C. pinnatifida Bunge (Shanzha) extract, indicating that the flavonoid glycoside and flavane polymers in C. pinnatifida Bunge (Shanzha) extract can antagonize digoxin-induced arrhythmias (Li and Huang, 2016), which may be related to their ability to dilate blood vessels, lower blood pressure, slow down the heart rhythm, and improve the cardiovascular system (Zhang et al., 2021).","label":[[48,100,"Pathology"],[104,129,"Pathology"],[144,155,"Pathology"],[179,209,"Herb name"],[221,228,"Drug"],[237,248,"Pathology"],[281,305,"Pathology"],[313,320,"Drug"],[398,429,"Herb name"],[458,478,"Herb name"],[481,498,"Herb name"],[502,533,"Herb name"],[556,563,"Drug"],[572,584,"Pathology"],[674,689,"Parameter"],[705,717,"Parameter"]],"Comments":[]}
{"id":6476,"text":"2-Aminoethanesulfonic acid (taurine) is a sulfur-containing non-protein amino acid isolated from Calculus Bovis.","label":[],"Comments":[]}
{"id":6477,"text":"In a study in dogs, an initial dose of 35 μg\/kg digoxin was administered intravenously to dogs with severed vagus nerves, followed by 17.5 μg every half hour until the electrocardiogram T-wave reversal and premature beats started to show toxic reactions, after which 2-aminoethanesulfonic acid was injected into the femoral vein at 0.5 mmoL\/kg every 15 min.","label":[[38,47,"Amount"],[48,56,"Drug"],[134,141,"Amount"],[332,343,"Amount"],[343,356,"Frequency"]],"Comments":[]}
{"id":6478,"text":"The results showed that the electrocardiogram returned to normal, probably because 2-aminoethanesulfonic acid was converted to acyl thiourea intracellularly, reducing the digoxin-induced arrhythmia (Read and Welty, 1963).","label":[[171,178,"Drug"],[187,198,"Pathology"]],"Comments":[]}
{"id":6479,"text":"In conclusion, TCM interacting with digoxin comprises monomer components, single medicines, and Chinese patent medicines.","label":[[36,44,"Drug"],[96,104,"Ethnic group"]],"Comments":[]}
{"id":6480,"text":"They can influence the pharmacokinetic process and pharmacodynamics of digoxin, resulting in changes in pharmacokinetic parameters, enhanced efficacy and even poisoning of digoxin.","label":[[71,78,"Drug"],[172,179,"Drug"]],"Comments":[]}
{"id":6481,"text":"Some of the above changes are clear, while others are speculated to have potential risks through the mechanism of action, which need further study and confirmation.","label":[],"Comments":[]}
{"id":6482,"text":"The following table summarizes and analyzes the interaction between Chinese medicine and digoxin from the aspects of the outcome, types of Chinese medicine, research objects, influence mechanism and changes in pharmacokinetic parameters of digoxin (See Table 1).","label":[[68,76,"Ethnic group"],[89,97,"Drug"],[139,147,"Ethnic group"],[240,248,"Drug"]],"Comments":[]}
{"id":6483,"text":"Interactions between TCM formulations and digoxin, and the underlying mechanisms.","label":[[42,49,"Drug"]],"Comments":[]}
{"id":6484,"text":"Digoxin is a cardiac glycoside drug commonly used in clinical practice for the treatment of heart failure, atrial fibrillation, and other arrhythmias, with a low therapeutic index, a narrow safety range, and large individual differences.","label":[[0,8,"Drug"],[92,105,"Pathology"],[107,126,"Pathology"],[138,149,"Pathology"]],"Comments":[]}
{"id":6485,"text":"It needs to be taken for a long time, and it is often applied in combination with other drugs, especially TCM formulations, in China, which complicates the plasma concentration of digoxin and is prone to poisoning due to the complexity of TCM formulations.","label":[[156,187,"Parameter"],[180,188,"Drug"]],"Comments":[]}
{"id":6486,"text":"In addition, some diets in daily life can also interfere with digoxin plasma concentration.","label":[[27,33,"Frequency"],[61,90,"Parameter"],[62,70,"Drug"]],"Comments":[]}
{"id":6487,"text":"Therefore, clinicians and pharmacists need to understand the interactions between digoxin and TCM formulations to avoid the occurrence of ADRs or even toxic reactions and promote the rational clinical use of drugs.","label":[[82,90,"Drug"],[138,142,"Pathology"]],"Comments":[]}
{"id":6488,"text":"In this paper, we summarize interactions with digoxin and their mechanisms.","label":[[46,54,"Drug"]],"Comments":[]}
{"id":6489,"text":"The mechanisms of TCM interactions with digoxin are summarized from the following five perspectives (Figure 2).","label":[[40,48,"Drug"]],"Comments":[]}
{"id":6490,"text":"Interactions between TCM formulations and digoxin.","label":[[42,49,"Drug"]],"Comments":[]}
{"id":6491,"text":"Status of the gastrointestinal tract and digoxin absorption: TCM formulations containing tropane alkaloids may reduce gastrointestinal motility, delaying absorption and increasing bioavailability; TCM formulations containing large amounts of tannins that cause changes in the pH of the gastrointestinal tract, such as   Regulation of P-gP affecting the digoxin disposal process: 1) Inhibition or downregulation of P-gP: the monoterpenoid citronellal, flavonoids such as nobiletin, quercetin, lanosterin, and catarrhal xanthin inhibit P-gP activity or suppress P-gP expression, increase plasma concentration of digoxin, and increase bioavailability.","label":[[41,49,"Drug"],[41,59,"Parameter"],[89,106,"Herb name"],[118,143,"Parameter"],[154,165,"Parameter"],[180,195,"Parameter"],[242,250,"Herb name"],[276,279,"Parameter"],[334,338,"Target"],[353,361,"Drug"],[414,418,"Target"],[424,449,"Herb name"],[470,479,"Herb name"],[481,490,"Herb name"],[492,502,"Herb name"],[508,526,"Herb name"],[533,538,"Target"],[560,564,"Target"],[586,617,"Parameter"],[610,617,"Drug"],[632,647,"Parameter"]],"Comments":[]}
{"id":6492,"text":"Ginsenosides inhibit P-gP transport and compete for P-gP binding sites to increase digoxin plasma concentration.","label":[[0,13,"Herb name"],[20,25,"Target"],[51,56,"Target"],[82,111,"Parameter"],[83,91,"Drug"]],"Comments":[]}
{"id":6493,"text":"C. anthriscoides “Chuanxiong” influences Ca Medicinal and edible homologous substances are edible and medicinal Chinese herbal medicines used in TCM and diet therapy based on the guidance of the concept of homologous medicine and food.","label":[[0,29,"Herb name"],[112,120,"Ethnic group"]],"Comments":[]}
{"id":6494,"text":"The application history has a long history, which is recorded in “Shen Nong’s Classic of the Materia Medica”, “The Grand Compendium of Materia Medica” and other books.","label":[[66,107,"Herb name"],[93,107,"Herb name"],[134,149,"Herb name"]],"Comments":[]}
{"id":6495,"text":"For example, the ancients used edible bark in nature and processed it into food to replace food to satisfy hunger, which played a role in satisfying and curing diseases.","label":[],"Comments":[]}
{"id":6496,"text":"The buds, seedlings, leaves, or flowers of medicinal plants with the homology of medicine and food in wood are processed into drinks, which have good taste, and can play a role in healthcare and conditioning discomfort symptoms after long-term use.","label":[[4,8,"Herb part"],[10,19,"Herb part"],[21,27,"Herb part"],[32,40,"Herb part"],[208,227,"Pathology"]],"Comments":[]}
{"id":6497,"text":"With the rapid development of social economy, modern life makes people have higher expectations and pursuit for physical and mental health.","label":[],"Comments":[]}
{"id":6498,"text":"Medicinal varieties with the homology of medicine and food should be paid attention to.","label":[],"Comments":[]}
{"id":6499,"text":"Most medicinal plants with the homology of medicine and food are gentle in nature, warm in nature and sweet in taste.","label":[],"Comments":[]}
{"id":6500,"text":"When the bias of medicine is greater than that of food, it will inevitably affect the balance of qi, blood, yin and yang of the human body (Jia et al., 2021).","label":[],"Comments":[]}
{"id":6501,"text":"The homology of medicine and food does not mean that medicine and food are the same.","label":[],"Comments":[]}
{"id":6502,"text":"In practical application, special attention should be paid to the difference between medicine and food.","label":[],"Comments":[]}
{"id":6503,"text":"Excessive or improper consumption can easily lead to toxicity (bias).","label":[[53,62,"Pathology"]],"Comments":[]}
{"id":6504,"text":"While knowing its edible value, we should also pay attention to its medicinal value, so as to avoid drug interaction and affect the treatment of diseases.","label":[],"Comments":[]}
{"id":6505,"text":"Synergistic drug effects increase the risk of digoxin poisoning: Venenum bufonis has a cardiac glycoside structure, inhibits Na  Enhanced sensitivity of the heart to digoxin and increased risk of toxicity: G. glabra L. (Gancao) has deoxycorticosterone-like effects, which can “conserve sodium and drain potassium,” easily causing hypokalemia, increasing the sensitivity of myocardium to digoxin, and inducing digoxin toxicity in therapeutic doses.","label":[[46,54,"Drug"],[65,80,"Herb name"],[87,104,"Herb name"],[125,129,"Target"],[166,174,"Drug"],[196,204,"Pathology"],[206,227,"Herb name"],[387,394,"Drug"],[409,417,"Drug"],[417,426,"Pathology"]],"Comments":[]}
{"id":6506,"text":"Antagonize digoxin-induced ADR: A. sinensis (Oliv.)","label":[[11,18,"Drug"],[32,51,"Herb name"]],"Comments":[]}
{"id":6507,"text":"Diels (Danggui) has anti-arrhythmic effects; C. pinnatifida Bunge (Shanzha) extract contains flavonoid glycosides and flavane polymers that can dilate blood vessels, lower the blood pressure, and slow down the heart rhythm; 2-aminoethanesulfonic acid is converted to acyl thiourea intracellularly, reducing the cellular response to digoxin-induced arrhythmia.","label":[[0,16,"Herb name"],[45,75,"Herb name"],[93,114,"Herb name"],[118,134,"Herb name"],[176,190,"Parameter"],[210,222,"Parameter"],[332,339,"Drug"],[348,358,"Pathology"]],"Comments":[]}
{"id":6508,"text":"All the above herbs can antagonize the arrhythmic toxic reactions induced by digoxin.","label":[[77,84,"Drug"]],"Comments":[]}
{"id":6509,"text":"Although a lot of experience has been accumulated in the clinical application of digoxin over the years, limited research has been conducted on its possible interactions with TCM formulations.","label":[[81,89,"Drug"]],"Comments":[]}
{"id":6510,"text":"The mechanisms of interaction between TCM formulations and digoxin have been basically elucidated in terms of pharmacokinetics and pharmacodynamics in cells, animals, and humans.","label":[[59,67,"Drug"]],"Comments":[]}
{"id":6511,"text":"Based on the reported pharmacological effects and existing research results, some Chinese herbal medicines may have potential interaction with digoxin.","label":[[82,90,"Ethnic group"],[143,150,"Drug"]],"Comments":[]}
{"id":6512,"text":"The following problems were found in the present analysis: i) Existing studies on the effects of TCM formulations on P-gP mainly focus on a certain component or a single drug, while few studies have been conducted on Chinese patent medicines containing these components.","label":[[117,121,"Target"],[217,225,"Ethnic group"]],"Comments":[]}
{"id":6513,"text":"ii) Studies have been conducted on the interactions of TCM extracts with digoxin, but the specific components of the extracts were not identified.","label":[[73,80,"Drug"]],"Comments":[]}
{"id":6514,"text":"For example, a study showed that a small molecule component of the water-soluble part of B. chinense DC.","label":[[88,104,"Herb name"]],"Comments":[]}
{"id":6515,"text":"(Chaihu) has an induction effect on P-gP, but its water-soluble part contains a variety of monosaccharides, oligosaccharides, amino acids, and other components, and it is not clear which component causes the interaction.","label":[[1,7,"Herb name"],[36,41,"Target"],[91,106,"Herb name"],[108,124,"Herb name"],[126,137,"Herb name"]],"Comments":[]}
{"id":6516,"text":"iii) The results of the interactions between Chinese patent medicines, TCM formulations, and digoxin are inconsistent.","label":[[45,53,"Ethnic group"],[93,101,"Drug"]],"Comments":[]}
{"id":6517,"text":"For example, P. ginseng C.A.Mey.","label":[[13,32,"Herb name"]],"Comments":[]}
{"id":6518,"text":"enhances the effect of digoxin, but Shenmai injection (a Chinese patent medicine containing P. ginseng C.A.Mey.)","label":[[23,30,"Drug"],[36,53,"Herb name"],[57,65,"Ethnic group"],[92,112,"Herb name"]],"Comments":[]}
{"id":6519,"text":"promotes the renal excretion of digoxin and decreases digoxin plasma concentration; G. biloba L. (Yinxing) has no effect on the pharmacokinetic parameters of digoxin, while G. biloba L. extract has a significant effect and increases digoxin plasma concentration.","label":[[32,40,"Drug"],[54,62,"Drug"],[54,82,"Parameter"],[83,106,"Herb name"],[158,165,"Drug"],[172,185,"Herb name"],[233,241,"Drug"],[233,261,"Parameter"]],"Comments":[]}
{"id":6520,"text":"These discrepancies may be related to the formulation of the Chinese patent medicine, the dose, the assay method, and other factors; further study is necessary.","label":[[61,69,"Ethnic group"]],"Comments":[]}
{"id":6521,"text":"iv) The pharmacological effects of TCM formulations are complex, and most of the current studies have been conducted in cells and animals.","label":[],"Comments":[]}
{"id":6522,"text":"Whether TCM formulations that can regulate P-gP also interfere with human digoxin plasma concentration needs further clinical validation.","label":[[42,47,"Target"],[74,82,"Drug"]],"Comments":[]}
{"id":6523,"text":"In view of the above problems in the research of the interaction between TCM and digoxin, the following solutions are put forward: 1) Because of the complex components of TCM, the pharmacology of some TCMs has not been clarified.","label":[[81,88,"Drug"]],"Comments":[]}
{"id":6524,"text":"It is suggested that network pharmacology should be used to clarify the components and mechanism of TCM in the future.","label":[],"Comments":[]}
{"id":6525,"text":"2) For Chinese medicines found to have exact or potential interaction with digoxin, it is suggested to study from different levels of monomer, single medicine, ready-for-use TCM or prescription in the future to confirm whether the action with digoxin is related to a certain component, a certain medicine, mutual compatibility, processing and other factors.","label":[[7,15,"Ethnic group"],[75,82,"Drug"],[243,251,"Drug"]],"Comments":[]}
{"id":6526,"text":"3) At present, most of the research data come from animal experiments or cells.","label":[],"Comments":[]}
{"id":6527,"text":"For TCMs that have interaction found in vitro studies, it is suggested to further conduct clinical research to provide basis for the safe combination of digoxin and TCMs.","label":[[36,53,"Study"],[153,161,"Drug"]],"Comments":[]}
{"id":6528,"text":"4) The combination of Chinese and Western medicine is not only simply adding Chinese medicine with Western medicine, but it should also be a combination of the theoretical basis and scientific medication principles.","label":[[22,30,"Ethnic group"],[77,85,"Ethnic group"]],"Comments":[]}
{"id":6529,"text":"It is suggested that clinicians, while ensuring clinical efficacy, should scientifically and reasonably select digoxin to combine with TCM, monitor the blood concentration of digoxin, record the patient information, the dosage, course of treatment and combination of digoxin, and establish a database of the combination of digoxin and TCM, so as to timely find out the TCM that may interact with digoxin, provide data support, and play a warning role in the clinical drug combination.","label":[[111,119,"Drug"],[152,182,"Parameter"],[175,182,"Drug"],[195,203,"Pathology"],[267,274,"Drug"],[323,331,"Drug"],[396,403,"Drug"]],"Comments":[]}
{"id":6530,"text":"Among the factors affecting the pharmacokinetics and pharmacodynamics of digoxin, special population (elderly people, people with abnormal renal function), genes and races are mentioned, mainly considering that the safety range of digoxin itself is narrow, and there are many factors affecting the blood concentration of digoxin, among which special population, genes and races will also affect the blood concentration of digoxin.","label":[[73,80,"Drug"],[130,153,"Pathology"],[231,239,"Drug"],[297,328,"Parameter"],[321,328,"Drug"],[398,429,"Parameter"],[422,429,"Drug"]],"Comments":[]}
{"id":6531,"text":"Because of the decrease of renal blood flow, glomerular filtration rate and renal excretion function in the elderly, the blood concentration of digoxin increased obviously.","label":[[27,43,"Parameter"],[45,72,"Parameter"],[120,151,"Parameter"],[144,152,"Drug"]],"Comments":[]}
{"id":6532,"text":"Digoxin mainly passes through glomerular filtration and is excreted in its original form in human body.","label":[[0,8,"Drug"]],"Comments":[]}
{"id":6533,"text":"Because of the decrease of glomerular filtration rate and the prolongation of half-life, the blood concentration of digoxin is significantly increased in patients with renal insufficiency, and it is easy to appear poisoning (Xia, 2017).","label":[[27,54,"Parameter"],[92,123,"Parameter"],[116,124,"Drug"],[154,163,"Pathology"],[168,187,"Pathology"]],"Comments":[]}
{"id":6534,"text":"The research has demonstrated that genes (Jiang et al., 2019) and ethics (Yan et al., 2015) have an impact on the blood concentration of digoxin, which reminds patients to consider the individualization of clinical medication and ask the basic information of patients carefully, which provides a new angle for the study of blood concentration of digoxin.","label":[[114,144,"Parameter"],[137,144,"Drug"],[160,169,"Pathology"],[323,353,"Parameter"],[346,353,"Drug"]],"Comments":[]}
{"id":6535,"text":"For patients with abnormal digoxin blood concentration or poisoning which are difficult to be explained by existing research theories, gene detection, gene sequencing, race and geographical origin of patients can be considered, which may provide new influencing factors for the safe use of digoxin in the future.","label":[[4,13,"Pathology"],[27,35,"Drug"],[27,54,"Parameter"]],"Comments":[]}
{"id":6536,"text":"Considering the narrow therapeutic window of digoxin, the effective therapeutic dose is not easy to determine, and it is prone to poor efficacy or toxic reactions (Englund et al., 2004).","label":[[45,52,"Drug"]],"Comments":[]}
{"id":6537,"text":"P-gP inhibitors applied in combination are positively correlated with patients’ digoxin plasma concentration.","label":[[0,4,"Target"],[70,78,"Pathology"],[80,88,"Drug"],[80,108,"Parameter"]],"Comments":[]}
{"id":6538,"text":"Therefore, when combining digoxin with one or more P-gP inhibitors, clinicians or pharmacists should consider the patient’s condition, the TCM components, the interactions between digoxin and TCM formulations, and the compatibility between drugs.","label":[[26,34,"Drug"],[50,56,"Target"],[114,124,"Pathology"],[180,188,"Drug"]],"Comments":[]}
{"id":6539,"text":"Moreover, the plasma concentration of digoxin should be monitored to pay close attention to its efficacy and toxicity and to the interaction between digoxin and TCM formulations in clinical applications, with a view to develop better treatment options and to guide the rational and safe use of clinical drugs.","label":[[14,45,"Parameter"],[38,45,"Drug"],[149,157,"Drug"]],"Comments":[]}
{"id":6540,"text":"With the popularization of TCM and the improvement of living standards, elderly patients who have been taking digoxin for a long time tend to take TCM on their own.","label":[[80,89,"Pathology"],[110,118,"Drug"]],"Comments":[]}
{"id":6541,"text":"Digoxin has a narrow safety range, i.e., the therapeutic and toxic doses are close to each other, and it is associated with large individual differences.","label":[[0,8,"Drug"]],"Comments":[]}
{"id":6542,"text":"Drug interactions have a great effect on digoxin plasma concentration and cause toxic reactions.","label":[[41,49,"Drug"]],"Comments":[]}
{"id":6543,"text":"The composition of TCM formulations is complex.","label":[],"Comments":[]}
{"id":6544,"text":"Therefore, the interactions between TCM formulations and digoxin are difficult to elucidate, and they are easily ignored by physicians.","label":[],"Comments":[]}
{"id":6545,"text":"When patients take digoxin, they should take into account other medications and digoxin plasma concentration should be monitored to ensure efficacy and safety.","label":[[19,26,"Drug"],[80,88,"Drug"],[80,108,"Parameter"]],"Comments":[]}
{"id":6546,"text":"Doctors and pharmacists should screen patients for the TCM formulations mentioned in this paper that have interactions with digoxin, monitor the use of interacting drugs such as those containing flavonoids or calcium, those affecting P-gP, and herbal medicines with cardiac potency, and adjust the type and dose of medication according to the monitoring results and clinical symptoms to prevent or reduce the occurrence of ADRs and improve efficacy and safety.","label":[[38,47,"Pathology"],[124,131,"Drug"],[195,206,"Herb name"],[234,238,"Target"],[423,427,"Pathology"]],"Comments":[]}
{"id":6547,"text":"WZ and TH wrote the manuscript.","label":[],"Comments":[]}
{"id":6548,"text":"WZ, TH, Z-ZW, and B-BJ searched for related studies.","label":[],"Comments":[]}
{"id":6549,"text":"B-BJ and LZ proofread the manuscript.","label":[],"Comments":[]}
{"id":6550,"text":"S-YX and X-ZD guided the writing and critically revised the manuscript.","label":[],"Comments":[]}
{"id":6551,"text":"All authors have read and approved the final version of the manuscript.","label":[],"Comments":[]}
{"id":6552,"text":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","label":[],"Comments":[]}
{"id":6553,"text":"All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.","label":[],"Comments":[]}
{"id":6554,"text":"Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.","label":[],"Comments":[]}
{"id":6555,"text":"ABC, ATP-binding cassette transporter; ADR, adverse reaction; AUC, area under the curve; C","label":[[39,42,"Pathology"],[39,60,"Pathology"],[62,90,"Parameter"]],"Comments":[]}
